-
Deferiprone Workflows for Iron Stress Assays
2026-08-21
Deferiprone enables controlled iron depletion for enterocyte, tumor, oxidative-stress, and drug-injury experiments without relying on DMSO-based stocks. This guide translates enterocyte metabolomics findings into practical dose-ranging, repletion, apoptosis, and troubleshooting workflows.
-
SB 202190: p38 MAP Kinase Inhibitor Workflows
2026-08-20
SB 202190 is a cell-permeable, ATP-competitive p38 MAP kinase inhibitor for separating p38α/β signaling from parallel pathways in inflammation, cancer, and neuronal assays. This practical guide combines dose planning, acute phospho-signaling workflows, long-exposure apoptosis studies, and controls inspired by pancreatic acinar cell research.
-
Vincristine sulfate: Reliable Assay Design
2026-08-19
Learn how Vincristine sulfate (SKU A1765) can improve the interpretability and repeatability of cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects microtubule biology with practical stock preparation, assay controls, dose interpretation, and vendor selection.
-
Reversine: Practical Aurora Kinase Workflow
2026-08-19
Reversine is an Aurora kinase inhibitor for controlled studies of mitotic regulation, cell-cycle checkpoints, and cancer cell proliferation inhibition. This guide covers preparation, assay controls, and interpretation limits; the compound is for research use only and should not be used for diagnosis, treatment, or clinical decision-making.
-
Hexamethonium Bromide in Autonomic Studies
2026-08-18
Hexamethonium Bromide provides a pharmacological way to localize autonomic ganglia contributions in neuronal signaling pathway research. This article interprets ganglionic blockade alongside telemetry, baroreflex analysis, sex as a biological variable, and practical reagent controls.
-
PLAC1 in ccRCC: Biomarker and Molecular Target
2026-08-18
A 2025 Cellular Signalling study identifies PLAC1 as an adverse prognostic marker and functional driver in clear cell renal cell carcinoma. By combining TCGA analysis, experimental PLAC1 depletion, and high-throughput virtual screening, the authors nominate Amaronol B and canagliflozin as compounds that reduce PLAC1 expression and suppress ccRCC progression in vitro.
-
Aconitase Activity Colorimetric Assay Kit for T Cells
2026-08-17
Use the Aconitase Activity Colorimetric Assay Kit to connect functional TCA-cycle activity with oxidative stress and CD8+ T-cell metabolic studies. Its rapid 450 nm colorimetric endpoint supports comparative lysate testing, time-course experiments, and higher-throughput screening without treating aconitase abundance as a substitute for enzyme function.
-
Deferiprone: Reading Cellular Iron Stress
2026-08-16
Deferiprone is more than an iron chelator: it can serve as a controlled perturbation for mapping how iron availability reshapes metabolism, proliferation, and inflammatory signaling. This article connects enterocyte metabolomics with cancer biology, doxorubicin protection, and neurovascular research while emphasizing assay interpretation and reproducibility.
-
Ciclesonide Workflows for Respiratory Research
2026-08-15
Build more informative respiratory assays by tracking Ciclesonide activation, glucocorticoid receptor signaling, and anti-inflammatory outcomes in the same workflow. The article also shows how ERAD-hijacking research can guide assay design without overstating evidence for Ciclesonide as a targeted protein degrader.
-
PBS (Phosphate-Buffered Saline): Lab Guide
2026-08-15
PBS (Phosphate-Buffered Saline), SKU K2818, is a sterile, isotonic, ready-to-use solution for cell washing, reagent dilution, and selected in vitro assay workflows requiring controlled pH and ionic conditions. It is intended for scientific research only, not for diagnostic, clinical, medical, or in vivo use, and should be stored at -20°C for stability.
-
Nullscript: Histone Deacetylase Inhibitor Guide
2026-08-14
Nullscript is a mechanistic HDAC probe that separates enzyme inhibition from transcriptional facilitation, making it useful for chromatin, cardiac ischemia/reperfusion, and pathway-dissection studies. This guide outlines practical formulation, assay design, cross-domain interpretation, and troubleshooting strategies while distinguishing established product evidence from proposed workflows.
-
Oxaliplatin in Tumor–Stroma Translation
2026-08-14
Oxaliplatin is more than a DNA-damaging benchmark: its translational value depends on how tumor context, stromal signaling, and model architecture shape response. Patient-derived gastric cancer assembloids offer a strategic framework for testing this platinum-based chemotherapeutic agent in biologically realistic settings while informing metastatic colorectal cancer therapy, resistance studies, and personalized cancer chemotherapy.
-
4-Hydroxytamoxifen: Protocol and QC Guide
2026-08-13
4-Hydroxytamoxifen (SKU B6167) is a DMSO-compatible estrogen receptor modulator for controlled in vitro receptor, cancer-cell, apoptosis, and cardiac myocyte workflows. It is not suitable for protocols requiring water or ethanol solubility, and long-term storage of prepared solutions should not be assumed.
-
CDK4/6–BET Synergy in Pancreatic Cancer
2026-08-13
Gu et al. show that combining the CDK4/6 inhibitor palbociclib with the BET inhibitor JQ1 can suppress pancreatic ductal adenocarcinoma more effectively than either agent alone. The study explains how CDK4/6 blockade may activate GSK3β-mediated Wnt/β-catenin signaling and promote epithelial-to-mesenchymal transition, while BET inhibition counteracts this adaptive response.
-
Deferiprone for Iron-Stress Cell Assays
2026-08-12
Deferiprone enables controlled iron-depletion experiments spanning enterocyte metabolism, cancer biology, oxidative stress, and apoptosis. This workflow emphasizes fresh aqueous preparation, time-resolved controls, iron repletion, and orthogonal readouts to distinguish iron-dependent signaling modulation from nonspecific toxicity.
447 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page